First Light Asset Management as of Sept. 30, 2015
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 62 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 9.7 | $20M | 899k | 21.91 | |
| NeoGenomics (NEO) | 8.4 | $17M | 3.0M | 5.73 | |
| RTI Biologics | 5.6 | $11M | 2.0M | 5.68 | |
| Akorn | 4.6 | $9.2M | 325k | 28.50 | |
| Tearlab Corp | 3.7 | $7.6M | 3.8M | 2.01 | |
| Harvard Bioscience (HBIO) | 3.7 | $7.5M | 2.0M | 3.78 | |
| Enzo Biochem (ENZ) | 3.5 | $7.1M | 2.2M | 3.17 | |
| Oxford Immunotec Global | 3.5 | $7.0M | 521k | 13.50 | |
| LHC | 3.4 | $6.8M | 152k | 44.77 | |
| IGI Laboratories | 3.3 | $6.6M | 1.0M | 6.54 | |
| Omnicell (OMCL) | 2.6 | $5.4M | 172k | 31.10 | |
| Insmed (INSM) | 2.5 | $5.1M | 272k | 18.57 | |
| Bio-techne Corporation (TECH) | 2.5 | $5.0M | 54k | 92.45 | |
| Ligand Pharmaceuticals In (LGND) | 2.4 | $4.9M | 58k | 85.65 | |
| Cynapsus Therapeutics | 2.4 | $4.9M | 302k | 16.17 | |
| Physicians Realty Trust | 2.4 | $4.9M | 322k | 15.09 | |
| LeMaitre Vascular (LMAT) | 2.3 | $4.6M | 376k | 12.19 | |
| Array BioPharma | 2.2 | $4.5M | 989k | 4.56 | |
| Entellus Medical Cm | 2.2 | $4.4M | 243k | 18.02 | |
| Quidel Corporation | 1.9 | $3.8M | 201k | 18.88 | |
| NxStage Medical | 1.9 | $3.8M | 240k | 15.77 | |
| Alkermes (ALKS) | 1.9 | $3.8M | 64k | 58.68 | |
| AngioDynamics (ANGO) | 1.8 | $3.7M | 277k | 13.19 | |
| Spectranetics Corporation | 1.7 | $3.4M | 286k | 11.79 | |
| Medicines Company | 1.6 | $3.2M | 84k | 37.97 | |
| Cepheid | 1.4 | $2.9M | 64k | 45.20 | |
| Streamline Health Solutions (STRM) | 1.4 | $2.9M | 1.3M | 2.29 | |
| Arrowhead Research | 1.3 | $2.7M | 466k | 5.76 | |
| Veracyte (VCYT) | 1.3 | $2.6M | 565k | 4.69 | |
| HealthStream (HSTM) | 1.3 | $2.6M | 118k | 21.81 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $2.6M | 25k | 104.13 | |
| Celldex Therapeutics | 1.1 | $2.3M | 215k | 10.54 | |
| Endologix | 1.1 | $2.2M | 181k | 12.26 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $2.0M | 19k | 105.31 | |
| Karyopharm Therapeutics (KPTI) | 0.8 | $1.6M | 155k | 10.53 | |
| Bluebird Bio (BLUE) | 0.6 | $1.2M | 14k | 85.52 | |
| Esperion Therapeutics (ESPR) | 0.6 | $1.1M | 48k | 23.58 | |
| Aratana Therapeutics | 0.3 | $701k | 83k | 8.45 | |
| Humana (HUM) | 0.3 | $634k | 3.5k | 179.10 | |
| Aetna | 0.3 | $571k | 5.2k | 109.49 | |
| Novartis (NVS) | 0.3 | $558k | 6.1k | 91.93 | |
| Endo International (ENDPQ) | 0.3 | $565k | 8.2k | 69.23 | |
| Anthem (ELV) | 0.3 | $573k | 4.1k | 139.93 | |
| Allergan | 0.3 | $553k | 2.0k | 271.74 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $501k | 3.8k | 131.15 | |
| Bristol Myers Squibb (BMY) | 0.2 | $491k | 8.3k | 59.23 | |
| Eli Lilly & Co. (LLY) | 0.2 | $460k | 5.5k | 83.71 | |
| Celgene Corporation | 0.2 | $463k | 4.3k | 108.18 | |
| Becton, Dickinson and (BDX) | 0.2 | $450k | 3.4k | 132.55 | |
| Steris Corporation | 0.2 | $411k | 6.3k | 64.93 | |
| St. Jude Medical | 0.2 | $382k | 6.1k | 63.09 | |
| Mylan Nv | 0.2 | $394k | 9.8k | 40.31 | |
| Johnson & Johnson (JNJ) | 0.2 | $357k | 3.8k | 93.46 | |
| AstraZeneca (AZN) | 0.2 | $361k | 11k | 31.78 | |
| Pfizer (PFE) | 0.2 | $330k | 11k | 31.37 | |
| Amgen (AMGN) | 0.2 | $322k | 2.3k | 138.20 | |
| Merck & Co (MRK) | 0.2 | $326k | 6.6k | 49.32 | |
| Myriad Genetics (MYGN) | 0.1 | $293k | 7.8k | 37.47 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $270k | 5.7k | 47.54 | |
| Community Health Systems (CYH) | 0.1 | $263k | 6.1k | 42.80 | |
| Sunopta (STKL) | 0.1 | $244k | 50k | 4.86 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $225k | 1.7k | 134.33 |
